Exchange: NASDAQ·Updated 07:51 PM EDT
News
all
press releases
EXCLUSIVE: Medicus Pharma Launches Genomics-Guided Endometriosis Study In Abu Dhabi
Medicus Pharma obtained UAE approval for its PRECISION-E2 Phase 2a clinical trial testing Teverelix in endometriosis patients.read more...
Benzinga
More News
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 56.1% to $4.62 during Monday's after-market session. The company's market cap stands at $1.7 million. Medicus Pharma (NASDAQ:MDCX) stock rose 7.46% toread more...
Benzinga
Is Medicus Pharma Ltd. (MDCX) Stock Gaining Momentum With Innovative Skin Cancer Treatment Technology?
Is Medicus Pharma Ltd. (MDCX) Stock Gaining Momentum With Innovative Skin Cancer Treatment Technology...
Yahoo! Finance: News
Medicus Pharma To Highlight SkinJect Phase 2 Data And Teverelix Clinical Advances At BIO 2026
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeuticread more...
Benzinga
Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook
Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook...
Yahoo! Finance: News
EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline
Medicus Pharma to present Phase 1 Teverelix data showing dose-dependent estradiol suppression and long-acting profile at AACE 2026.read more...
Benzinga
EXCLUSIVE: Medicus Pharma Refines Trial Design To Cut Costs, Accelerate Development For Enlarged Prostate Patients
Medicus Pharma submits Phase 2 design for Teverelix, targeting faster data readouts and lower costs in benign prostatic hyperplasiaread more...
Benzinga
Power Hour Surge: Biotech Cash Floods, Energy Breakouts, and AI Bets Drive the Stocks to Watch into the Close
As Wall Street heads into the final stretch of the trading day, capital flows into biotech financing, clean energy, and emerging technology platforms are shaping the stocks traders are watching most closely into the close and after-hours session. $EONR, $SAFX, $KBLB, $HIMS, $MDCX, $ANTX, $NVO, $MDCX, $RLMD, $SLDB, $ANTX, $EDIT, $DDD
24-7 Market News
Dow Falls Over 300 Points; Kroger Posts Mixed Results
US stocks down, Dow falls 300 points. Dow traded at 48,411.44, NASDAQ at 22,741.80, S&P 500 at 6,847.63. Energy shares rise, healthcare stocks dip. Kroger posts mixed results. Equities up for Impact...
Benzinga
Medicus Pharma Stock Swings After Skin Cancer Treatment Results
Medicus Pharma stock surged then slipped after the Phase 2 trial showed a 73% clearance rate for its skin cancer treatment.read more...
Benzinga

Advertisement|Remove ads.